FDA Website - Webinar on Guidances on COVID-19 Transition Plans The Webinar on Guidances on COVID-19 Transition Plans summarizes FDA’s April 18, 2023 stakeholder webinar explaining two final guidances for transitioning COVID-19-related medical devices from EUA/enforcement-policy flexibilities back to normal regulatory operations. It highlights recommendations on marketing submissions, timing, and a 180-day transition period with examples, along with Q&A addressing manufacturer and stakeholder implementation issues. primary file regulatory fda-policy 2023-04-18_FDA Website - Webinar on Guidances on COVID-19 Transition Plans.md regulatory/fda-policy/2023-04-18_FDA Website - Webinar on Guidances on COVID-19 Transition Plans.md 2023_04_18 date converted 2024-04-05 website Public Domain 437 655 gfile-url xfile-github-download-url pdf-gdrive-url pdf-github-url github-markdown-url github-markdown-download-url web-pdf-url web-slides-url youtube-url web-url